Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today ...

A research team led by scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) has introduced a new ...

Bacteria have long been a key source of lifesaving antibiotics, but most species cannot be grown in the lab—leaving their ...

Shares of Intellia Therapeutics NTLA soared 29.8% yesterday after the company announced that it has completed enrollment in ...

Detailed price information for Sonnet Biotherapeutics Holdings Inc (SONN-Q) from The Globe and Mail including charting and trades.

Extension of the Phase 1b study will allow participants to continue dosing with GT-02287 for an additional nine months after completing the first ...

All 27 patients completed treatment with no serious adverse events, underscoring a favorable safety profileStatistically significant improvements achieved across all efficacy endpoints at the 4-week ...

Regeneron on Wednesday said the Phase 3 study met its primary endpoint of a reduction in the number of new bone lesions compared to placebo in adults with FOP, a disorder in which muscles, tendons and ...

The article shows how microbiology teachers can use these films to spark curiosity, counter germophobia, and make complex concepts — from antibiotic discovery to biofuels — more engaging for students.

Data show a favorable safety profile and early efficacy signals in a heavily pre-treated population whose cancer progressed after multiple prior ...

Study did not meet primary endpoint in change from baseline in mean daily oral corticosteroid (OCS) dose at week 48, although ...

Reuters withdrew a video capturing hot mic remarks by Chinese President Xi Jinping and Russian President Vladimir Putin about ...